[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Doxorubicin Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

April 2022 | 130 pages | ID: GE5E77529B39EN
Maia Research

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Based on the Doxorubicin market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Doxorubicin market covered in Chapter 5:
Synbias Pharma
Pfizer
Meiji Seika Pharma
Sterling
LINGNAN Pharmaceutical
Teva
Johnson & Johnson
Sun Pharmaceutical Industries
MicroBiopharm Japan
Boryung

In Chapter 6, on the basis of types, the Doxorubicin market from 2015 to 2025 is primarily split into:
Doxorubicin Injection 10mg
Doxorubicin Injection 50mg

In Chapter 7, on the basis of applications, the Doxorubicin market from 2015 to 2025 covers:
Multiple Myeloma
Kaposi Sarcoma
Leukemia

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW

1.1 Product Definition and Market Characteristics
1.2 Global Doxorubicin Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. MARKET DYNAMICS

2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
  2.4.1 Short-term Impact
  2.4.2 Long-term Impact

3 ASSOCIATED INDUSTRY ASSESSMENT

3.1 Supply Chain Analysis
3.2 Industry Active Participants
  3.2.1 Suppliers of Raw Materials
  3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 MARKET COMPETITIVE LANDSCAPE

4.1 Industry Leading Players
4.2 Industry News
  4.2.1 Key Product Launch News
  4.2.2 M&A and Expansion Plans

5 ANALYSIS OF LEADING COMPANIES

5.1 Synbias Pharma
  5.1.1 Synbias Pharma Company Profile
  5.1.2 Synbias Pharma Business Overview
  5.1.3 Synbias Pharma Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.1.4 Synbias Pharma Doxorubicin Products Introduction
5.2 Pfizer
  5.2.1 Pfizer Company Profile
  5.2.2 Pfizer Business Overview
  5.2.3 Pfizer Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.2.4 Pfizer Doxorubicin Products Introduction
5.3 Meiji Seika Pharma
  5.3.1 Meiji Seika Pharma Company Profile
  5.3.2 Meiji Seika Pharma Business Overview
  5.3.3 Meiji Seika Pharma Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.3.4 Meiji Seika Pharma Doxorubicin Products Introduction
5.4 Sterling
  5.4.1 Sterling Company Profile
  5.4.2 Sterling Business Overview
  5.4.3 Sterling Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.4.4 Sterling Doxorubicin Products Introduction
5.5 LINGNAN Pharmaceutical
  5.5.1 LINGNAN Pharmaceutical Company Profile
  5.5.2 LINGNAN Pharmaceutical Business Overview
  5.5.3 LINGNAN Pharmaceutical Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.5.4 LINGNAN Pharmaceutical Doxorubicin Products Introduction
5.6 Teva
  5.6.1 Teva Company Profile
  5.6.2 Teva Business Overview
  5.6.3 Teva Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.6.4 Teva Doxorubicin Products Introduction
5.7 Johnson & Johnson
  5.7.1 Johnson & Johnson Company Profile
  5.7.2 Johnson & Johnson Business Overview
  5.7.3 Johnson & Johnson Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.7.4 Johnson & Johnson Doxorubicin Products Introduction
5.8 Sun Pharmaceutical Industries
  5.8.1 Sun Pharmaceutical Industries Company Profile
  5.8.2 Sun Pharmaceutical Industries Business Overview
  5.8.3 Sun Pharmaceutical Industries Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.8.4 Sun Pharmaceutical Industries Doxorubicin Products Introduction
5.9 MicroBiopharm Japan
  5.9.1 MicroBiopharm Japan Company Profile
  5.9.2 MicroBiopharm Japan Business Overview
  5.9.3 MicroBiopharm Japan Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.9.4 MicroBiopharm Japan Doxorubicin Products Introduction
5.10 Boryung
  5.10.1 Boryung Company Profile
  5.10.2 Boryung Business Overview
  5.10.3 Boryung Doxorubicin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.10.4 Boryung Doxorubicin Products Introduction

6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES

6.1 Global Doxorubicin Sales, Revenue and Market Share by Types (2015-2020)
  6.1.1 Global Doxorubicin Sales and Market Share by Types (2015-2020)
  6.1.2 Global Doxorubicin Revenue and Market Share by Types (2015-2020)
  6.1.3 Global Doxorubicin Price by Types (2015-2020)
6.2 Global Doxorubicin Market Forecast by Types (2020-2025)
  6.2.1 Global Doxorubicin Market Forecast Sales and Market Share by Types (2020-2025)
  6.2.2 Global Doxorubicin Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Doxorubicin Sales, Price and Growth Rate by Types (2015-2020)
  6.3.1 Global Doxorubicin Sales, Price and Growth Rate of Doxorubicin Injection 10mg
  6.3.2 Global Doxorubicin Sales, Price and Growth Rate of Doxorubicin Injection 50mg
6.4 Global Doxorubicin Market Revenue and Sales Forecast, by Types (2020-2025)
  6.4.1 Doxorubicin Injection 10mg Market Revenue and Sales Forecast (2020-2025)
  6.4.2 Doxorubicin Injection 50mg Market Revenue and Sales Forecast (2020-2025)

7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS

7.1 Global Doxorubicin Sales, Revenue and Market Share by Applications (2015-2020)
  7.1.1 Global Doxorubicin Sales and Market Share by Applications (2015-2020)
  7.1.2 Global Doxorubicin Revenue and Market Share by Applications (2015-2020)
7.2 Global Doxorubicin Market Forecast by Applications (2020-2025)
  7.2.1 Global Doxorubicin Market Forecast Sales and Market Share by Applications (2020-2025)
  7.2.2 Global Doxorubicin Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  7.3.1 Global Doxorubicin Revenue, Sales and Growth Rate of Multiple Myeloma (2015-2020)
  7.3.2 Global Doxorubicin Revenue, Sales and Growth Rate of Kaposi Sarcoma (2015-2020)
  7.3.3 Global Doxorubicin Revenue, Sales and Growth Rate of Leukemia (2015-2020)
7.4 Global Doxorubicin Market Revenue and Sales Forecast, by Applications (2020-2025)
  7.4.1 Multiple Myeloma Market Revenue and Sales Forecast (2020-2025)
  7.4.2 Kaposi Sarcoma Market Revenue and Sales Forecast (2020-2025)
  7.4.3 Leukemia Market Revenue and Sales Forecast (2020-2025)

8 MARKET ANALYSIS AND FORECAST, BY REGIONS

8.1 Global Doxorubicin Sales by Regions (2015-2020)
8.2 Global Doxorubicin Market Revenue by Regions (2015-2020)
8.3 Global Doxorubicin Market Forecast by Regions (2020-2025)

9 NORTH AMERICA DOXORUBICIN MARKET ANALYSIS

9.1 Market Overview and Prospect Analysis
9.2 North America Doxorubicin Market Sales and Growth Rate (2015-2020)
9.3 North America Doxorubicin Market Revenue and Growth Rate (2015-2020)
9.4 North America Doxorubicin Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Doxorubicin Market Analysis by Country
  9.6.1 U.S. Doxorubicin Sales and Growth Rate
  9.6.2 Canada Doxorubicin Sales and Growth Rate
  9.6.3 Mexico Doxorubicin Sales and Growth Rate

10 EUROPE DOXORUBICIN MARKET ANALYSIS

10.1 Market Overview and Prospect Analysis
10.2 Europe Doxorubicin Market Sales and Growth Rate (2015-2020)
10.3 Europe Doxorubicin Market Revenue and Growth Rate (2015-2020)
10.4 Europe Doxorubicin Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Doxorubicin Market Analysis by Country
  10.6.1 Germany Doxorubicin Sales and Growth Rate
  10.6.2 United Kingdom Doxorubicin Sales and Growth Rate
  10.6.3 France Doxorubicin Sales and Growth Rate
  10.6.4 Italy Doxorubicin Sales and Growth Rate
  10.6.5 Spain Doxorubicin Sales and Growth Rate
  10.6.6 Russia Doxorubicin Sales and Growth Rate

11 ASIA-PACIFIC DOXORUBICIN MARKET ANALYSIS

11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Doxorubicin Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Doxorubicin Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Doxorubicin Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Doxorubicin Market Analysis by Country
  11.6.1 China Doxorubicin Sales and Growth Rate
  11.6.2 Japan Doxorubicin Sales and Growth Rate
  11.6.3 South Korea Doxorubicin Sales and Growth Rate
  11.6.4 Australia Doxorubicin Sales and Growth Rate
  11.6.5 India Doxorubicin Sales and Growth Rate

12 SOUTH AMERICA DOXORUBICIN MARKET ANALYSIS

12.1 Market Overview and Prospect Analysis
12.2 South America Doxorubicin Market Sales and Growth Rate (2015-2020)
12.3 South America Doxorubicin Market Revenue and Growth Rate (2015-2020)
12.4 South America Doxorubicin Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Doxorubicin Market Analysis by Country
  12.6.1 Brazil Doxorubicin Sales and Growth Rate
  12.6.2 Argentina Doxorubicin Sales and Growth Rate
  12.6.3 Columbia Doxorubicin Sales and Growth Rate

13 MIDDLE EAST AND AFRICA DOXORUBICIN MARKET ANALYSIS

13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Doxorubicin Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Doxorubicin Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Doxorubicin Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Doxorubicin Market Analysis by Country
  13.6.1 UAE Doxorubicin Sales and Growth Rate
  13.6.2 Egypt Doxorubicin Sales and Growth Rate
  13.6.3 South Africa Doxorubicin Sales and Growth Rate

14 CONCLUSIONS AND RECOMMENDATIONS

14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 APPENDIX

15.1 Methodology
15.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Product Picture
Figure Global Doxorubicin Market Size and Growth Rate 2015-2025
Table Doxorubicin Key Market Segments
Figure Global Doxorubicin Market Revenue ($) Segment by Type from 2015-2020
Figure Global Doxorubicin Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Doxorubicin
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Synbias Pharma Company Profile
Table Synbias Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Synbias Pharma Production and Growth Rate
Figure Synbias Pharma Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Meiji Seika Pharma Company Profile
Table Meiji Seika Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Meiji Seika Pharma Production and Growth Rate
Figure Meiji Seika Pharma Market Revenue ($) Market Share 2015-2020
Table Sterling Company Profile
Table Sterling Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sterling Production and Growth Rate
Figure Sterling Market Revenue ($) Market Share 2015-2020
Table LINGNAN Pharmaceutical Company Profile
Table LINGNAN Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure LINGNAN Pharmaceutical Production and Growth Rate
Figure LINGNAN Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table Teva Company Profile
Table Teva Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Production and Growth Rate
Figure Teva Market Revenue ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020
Table Sun Pharmaceutical Industries Company Profile
Table Sun Pharmaceutical Industries Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sun Pharmaceutical Industries Production and Growth Rate
Figure Sun Pharmaceutical Industries Market Revenue ($) Market Share 2015-2020
Table MicroBiopharm Japan Company Profile
Table MicroBiopharm Japan Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure MicroBiopharm Japan Production and Growth Rate
Figure MicroBiopharm Japan Market Revenue ($) Market Share 2015-2020
Table Boryung Company Profile
Table Boryung Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Boryung Production and Growth Rate
Figure Boryung Market Revenue ($) Market Share 2015-2020
Table Global Doxorubicin Sales by Types (2015-2020)
Table Global Doxorubicin Sales Share by Types (2015-2020)
Table Global Doxorubicin Revenue ($) by Types (2015-2020)
Table Global Doxorubicin Revenue Share by Types (2015-2020)
Table Global Doxorubicin Price ($) by Types (2015-2020)
Table Global Doxorubicin Market Forecast Sales by Types (2020-2025)
Table Global Doxorubicin Market Forecast Sales Share by Types (2020-2025)
Table Global Doxorubicin Market Forecast Revenue ($) by Types (2020-2025)
Table Global Doxorubicin Market Forecast Revenue Share by Types (2020-2025)
Figure Global Doxorubicin Injection 10mg Sales and Growth Rate (2015-2020)
Figure Global Doxorubicin Injection 10mg Price (2015-2020)
Figure Global Doxorubicin Injection 50mg Sales and Growth Rate (2015-2020)
Figure Global Doxorubicin Injection 50mg Price (2015-2020)
Figure Global Doxorubicin Market Revenue ($) and Growth Rate Forecast of Doxorubicin Injection 10mg (2020-2025)
Figure Global Doxorubicin Sales and Growth Rate Forecast of Doxorubicin Injection 10mg (2020-2025)
Figure Global Doxorubicin Market Revenue ($) and Growth Rate Forecast of Doxorubicin Injection 50mg (2020-2025)
Figure Global Doxorubicin Sales and Growth Rate Forecast of Doxorubicin Injection 50mg (2020-2025)
Table Global Doxorubicin Sales by Applications (2015-2020)
Table Global Doxorubicin Sales Share by Applications (2015-2020)
Table Global Doxorubicin Revenue ($) by Applications (2015-2020)
Table Global Doxorubicin Revenue Share by Applications (2015-2020)
Table Global Doxorubicin Market Forecast Sales by Applications (2020-2025)
Table Global Doxorubicin Market Forecast Sales Share by Applications (2020-2025)
Table Global Doxorubicin Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Doxorubicin Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Multiple Myeloma Sales and Growth Rate (2015-2020)
Figure Global Multiple Myeloma Price (2015-2020)
Figure Global Kaposi Sarcoma Sales and Growth Rate (2015-2020)
Figure Global Kaposi Sarcoma Price (2015-2020)
Figure Global Leukemia Sales and Growth Rate (2015-2020)
Figure Global Leukemia Price (2015-2020)
Figure Global Doxorubicin Market Revenue ($) and Growth Rate Forecast of Multiple Myeloma (2020-2025)
Figure Global Doxorubicin Sales and Growth Rate Forecast of Multiple Myeloma (2020-2025)
Figure Global Doxorubicin Market Revenue ($) and Growth Rate Forecast of Kaposi Sarcoma (2020-2025)
Figure Global Doxorubicin Sales and Growth Rate Forecast of Kaposi Sarcoma (2020-2025)
Figure Global Doxorubicin Market Revenue ($) and Growth Rate Forecast of Leukemia (2020-2025)
Figure Global Doxorubicin Sales and Growth Rate Forecast of Leukemia (2020-2025)
Figure Global Doxorubicin Sales and Growth Rate (2015-2020)
Table Global Doxorubicin Sales by Regions (2015-2020)
Table Global Doxorubicin Sales Market Share by Regions (2015-2020)
Figure Global Doxorubicin Sales Market Share by Regions in 2019
Figure Global Doxorubicin Revenue and Growth Rate (2015-2020)
Table Global Doxorubicin Revenue by Regions (2015-2020)
Table Global Doxorubicin Revenue Market Share by Regions (2015-2020)
Figure Global Doxorubicin Revenue Market Share by Regions in 2019
Table Global Doxorubicin Market Forecast Sales by Regions (2020-2025)
Table Global Doxorubicin Market Forecast Sales Share by Regions (2020-2025)
Table Global Doxorubicin Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Doxorubicin Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure North America Doxorubicin Market Revenue and Growth Rate (2015-2020)
Figure North America Doxorubicin Market Forecast Sales (2020-2025)
Figure North America Doxorubicin Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Canada Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Mexico Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Europe Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Europe Doxorubicin Market Revenue and Growth Rate (2015-2020)
Figure Europe Doxorubicin Market Forecast Sales (2020-2025)
Figure Europe Doxorubicin Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure France Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Italy Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Spain Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Russia Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Doxorubicin Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Doxorubicin Market Forecast Sales (2020-2025)
Figure Asia-Pacific Doxorubicin Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Japan Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure South Korea Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Australia Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure India Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure South America Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure South America Doxorubicin Market Revenue and Growth Rate (2015-2020)
Figure South America Doxorubicin Market Forecast Sales (2020-2025)
Figure South America Doxorubicin Market Forecast Revenue ($) (2020-2025)
Figure Brazil Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Argentina Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Columbia Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Doxorubicin Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Doxorubicin Market Forecast Sales (2020-2025)
Figure Middle East and Africa Doxorubicin Market Forecast Revenue ($) (2020-2025)
Figure UAE Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure Egypt Doxorubicin Market Sales and Growth Rate (2015-2020)
Figure South Africa Doxorubicin Market Sales and Growth Rate (2015-2020)


More Publications